Novo Nordisk (NVO) earnings Q2 2025

Boxes of Ozempic and Wegovy made by Novo Nordisk at a pharmacy in London on March 8, 2024. Hollie Adams | Reuters Novo Nordisk on Wednesday posted second-quarter sales broadly in line with expectations, after last week cutting its full-year guidance and announcing its new CEO. Overall revenues rose 13% year-on-year at constant exchange rates…

Read More

Trump administration to pilot covering obesity drugs

A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Hollie Adams | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. For…

Read More

Lucid (LCID) results Q2 2025

A Lucid Air electric vehicle (EV) at the company’s showroom in Tysons, Virginia, US, on Saturday, Feb. 17, 2024. Samuel Corum | Bloomberg | Getty Images Lucid Group on Tuesday softened its production outlook for the rest of the year as it reported second-quarter earnings that missed Wall Street expectations. The electric vehicle maker now…

Read More

Snap shares plummet 15% after weak second-quarter revenue metric

Snap shares tanked more than 15% Tuesday when it reported second-quarter earnings in which global average revenue per user missed expectations. Here is how the company did compared with Wall Street’s expectations: Earnings per share: Loss of 16 cents. That figure is not comparable to analysts’ estimates. Revenue: $1.34 billion vs. $1.35 billion expected, according to LSEG …

Read More